Leveraging Expanded Access and Named-Patient Programs: Best Practices for Small and Emerging Biotech and Pharma Companies

Summary: Date Posted: 03/31/2010 Size: 6.64MB Length: 00:14:32 Thought Leader: Nicky Wisener, Biopharmaceutical Account Manager, Idis In this episode, Ms. Wisener describes how expanded access and named-patient programs can help successfully meet patients' needs while addressing the unique challenges faced by smaller and emerging companies. Play Podcast Download Whitepaper  For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.